Position in NVCR
as of Jun 30, 2026
· filed Aug 19, 2026
Position Value
$1,034,669
+$548,856 QoQ
Shares Held
68,295
+53.2% QoQ
Ownership
0.059%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#85
of 217 holders
Holding Since
Mar 2021
10 quarters on record
Voting authority
Sole 15%
Shared 0%
None 85%
Common Shares in NVCR Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026MERCER GLOBAL ADVISORS INC /ADV holds $220,215,684 across 64 Medical Devices names. NVCR ranks #18 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
609,854 | $55,338,151 | |
| 2 | SYK |
Stryker Corp
|
142,133 | $44,749,153 | |
| 3 | MDT |
Medtronic plc
|
504,928 | $39,500,517 | |
| 4 | EW |
Edwards Lifesciences Corp
|
279,851 | $25,315,321 | |
| 5 | BSX |
Boston Scientific Corp
|
206,605 | $8,817,901 | |
| 6 | DXCM |
Dexcom Inc
|
68,879 | $4,639,000 | |
| 7 | PODD |
Insulet Corp
|
27,766 | $4,227,373 | |
| 8 | STE |
STERIS plc
|
19,913 | $4,193,080 |
All Filings in NVCR
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,034,669 | 68,295 | Shares | Sole | 2026-08-19 | |
| 2026-03-31 | $485,813 | 44,570 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $422,293 | 32,660 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $368,685 | 28,536 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $238,092 | 13,376 | Shares | Sole | 2025-08-14 | |
| 2022-03-31 | $270,670 | 3,267 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $208,046 | 2,771 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $359,197 | 3,092 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $632,852 | 2,853 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $284,980 | 2,156 | Shares | Sole | 2021-08-10 | |
| No filing history on record for this holder in this stock. | ||||||